InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (47 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
47
T+90 hit rate
100%
T+90 mean return
+139.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Raab Michael, Chief Executive Officer. Insider active across 2 companies, notably Amicus Therapeutics, INC.. In total, 82 reports have been recorded. Split: 1 buy · 47 sells. Total volume traded: €3.7m. Activity tracked since 18 May 2021. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Raab Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations82 total
15,009 shares@ US$3.8569Common StockSEC:0001321402-26-000019:0
15,976 shares@ US$3.8569Common StockSEC:0001321402-26-000019:1
8,411 shares@ US$3.8569Common StockSEC:0001321402-26-000019:2
19,178 shares@ US$3.8569Common StockSEC:0001321402-26-000019:3
41,668 shares@ US$5.0620.017% mcap4.5% of flowCommon StockSEC:0001321402-26-000016:1
20,834 shares@ US$0.990.0016% mcap0.4% of flowCommon StockSEC:0001321402-26-000016:0
20,833 sharesCommon StockSEC:0001321402-26-000014:0
41,666 sharesCommon StockSEC:0001321402-26-000014:1
14,933 shares@ US$6.26750.0090% mcap2.5% of flowCommon StockSEC:0001321402-26-000012:0
17,926 shares@ US$6.26750.011% mcap3.1% of flowCommon StockSEC:0001321402-26-000012:2
14,028 shares@ US$6.26750.0084% mcap2.4% of flowCommon StockSEC:0001321402-26-000012:3
7,861 shares@ US$6.26750.0047% mcap1.3% of flowCommon StockSEC:0001321402-26-000012:1
41,666 shares@ US$6.27880.025% mcap7.1% of flowCommon StockSEC:0001321402-26-000009:1
20,833 shares@ US$0.990.0020% mcap0.6% of flowCommon StockSEC:0001321402-26-000009:0
115,857 shares@ US$14.500.036% mcap84.1% of flowCommon StockSEC:0001193125-26-182264:0
41,668 shares@ US$6.28670.019% mcap6.5% of flowCommon StockSEC:0001321402-26-000008:1
20,834 shares@ US$0.990.0015% mcap0.5% of flowCommon StockSEC:0001321402-26-000008:0
20,833 shares@ US$0.990.5% of flowCommon StockSEC:0001321402-26-000006:0
20,833 shares@ US$0.990.5% of flowCommon StockSEC:0001610717-26-000067:0
40,401 shares@ US$5.8655.4% of flowCommon StockSEC:0001610717-26-000058:0
446,220 shares0Common StockSEC:0001610717-26-000022:0
46,887 shares@ US$5.53697.1% of flowCommon StockSEC:0001610717-25-000396:0
45,687 shares@ US$5.93176.6% of flowCommon StockSEC:0001628280-25-041135:0
20,414 shares0Common StockSEC:0000950170-25-083223:0
46,817 shares@ US$4.08145.3% of flowCommon StockSEC:0001628280-25-027429:0
25 of 82 declarations
About Raab Michael
RAAB MICHAEL is Directeur Général. He has filed 76 filings, and over the period covered by the sampled filings from 2021-05-20 to 2026-06-17, the activity is mainly sales, with 1,849 EUR of buys and 4,760,143 EUR of sells, notably in Amicus Therapeutics, INC. and Ardelyx, INC.
